MedPath
HSA Approval

ENHANCIN TABLETS 625 mg

SIN11027P

ENHANCIN TABLETS 625 mg

ENHANCIN TABLETS 625 mg

July 19, 1999

RANBAXY (MALAYSIA) SDN. BHD.

RANBAXY (MALAYSIA) SDN. BHD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRANBAXY (MALAYSIA) SDN. BHD.
Licence HolderRANBAXY (MALAYSIA) SDN. BHD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01CR02

amoxicillin and beta-lactamase inhibitor

Manufacturer Information

RANBAXY (MALAYSIA) SDN. BHD.

SUN PHARMACEUTICAL INDUSTRIES LIMITED

Active Ingredients

CLAVULANATE POTASSIUM with Microcrystalline Cellulose (1:1) EQV CLAVULANIC ACID

125.00 mg

Clavulanic acid

Amoxicillin Trihydrate Eqv Amoxicillin

500 mg

Amoxicillin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.